RadNet Inc. (RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services, saw its stock plunge 9.72% in the after-hours session on Thursday. This sharp decline came after the company provided its financial guidance for the fiscal year 2025.
According to the guidance, RadNet expects to generate revenue in the range of $1.825 billion to $1.875 billion for FY25. This range fell short of the consensus estimate of $1.96 billion, disappointing investors and analysts who had anticipated stronger revenue growth.
While the company also provided guidance for adjusted EBITDA of $265 million to $273 million for FY25, the lack of a consensus estimate for this metric makes it difficult to assess whether the guidance met or missed expectations.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。